Comparing the current results to its competitors, Bio Rad Laboratories Inc reported Revenue decrease in the 2 quarter 2026 year on year by -0.05 %, despite the revenue increase by the most of its competitors of 7.96 %, recorded in the same quarter.
November 21, 2024
Bio-Rad Laboratories: Outperforming Rivals in a Competitive Healthcare Landscape As Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) prepares to engage directly with analysts and investors at Citi s 2024 Global Healthcare Conference, the company stands on firm ground. Under the leadership of CEO Norman Schwartz and CFO Roop K. Lakkaraju, Bio-Rad has managed to navigate a turbulent market with remarkable agility and strategic acumen a fact evidenced by their financial performance in the third quarter of 2024. Defying Industry Trends In a year where the healthcare industry has faced economic challenges and market contractions, Bio-Rad has not only weathered the storm but has also set itself apart from its comp...
10x Genomics Inc is a biotechnology company that specializes in providing tools and solutions for genomic research. Their business model revolves around developing innovative technologies and platforms to enable scientists and researchers to gain deeper insights into the structure and function of biological systems. They offer products such as single-cell sequencing and spatial transcriptomics to support various areas of genomics research and accelerate discoveries in fields like cancer research, immunology, and neuroscience.
Nautilus Biotechnology Inc's business model focuses on using advanced genomics and proteomics technologies to analyze and understand the human proteome.
Mettler toledo International Inc Share Performance
-10.24%
30 Days
Mettler toledo International Inc
Profile
Mettler Toledo International Inc. operates on a business model that focuses on providing high-quality precision instruments and solutions tailored for various industries, including pharmaceuticals, food production, and laboratory research. The company emphasizes innovation and customer-centric service, delivering advanced technology and software alongside its instruments to enhance operational efficiency and accuracy. Additionally, Mettler Toledo generates recurring revenue through maintenance services, calibration, and consumables associated with its products, fostering long-term relationships with its clients.
Maravai Lifesciences Holdings Inc's business model revolves around providing integrated solutions for the development and manufacturing of biopharmaceutical products.
Standard Biotools Inc operates as a biotechnology company that specializes in the development and distribution of standard laboratory tools and reagents. They offer a diverse range of high-quality products including lab equipment, molecular diagnostics, and research reagents to meet the needs of scientists and researchers in the life sciences industry. With a customer-centric approach, Standard Biotools aims to provide reliable and affordable solutions to support advancements in scientific research and discovery.
Sources:
Bio rad Laboratories Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Bio rad Laboratories Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
